Other Income & Expense

Derivative Gain (Loss) Excluded from Effectiveness

Morgan Stanley Derivative Gain (Loss) Excluded from Effectiveness remained flat by 0.0% to -$27.25M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 18.5%, from -$23.00M to -$27.25M. Over 4 years (FY 2021 to FY 2025), Derivative Gain (Loss) Excluded from Effectiveness shows a downward trend with a 67.0% CAGR.

Analysis

StatementIncome Statement
SectionOther Income & Expense
First reportedQ1 2014
Last reportedQ4 2025Feb 19, 2026
Metric ID: abbv_derivative_gain_loss_excluded_from_effectiveness

Historical Data

5 years
 FY'21FY'22FY'23FY'24FY'25
Value-$14.00M-$39.00M-$65.00M-$92.00M-$109.00M
YoY Change—-178.6%-66.7%-41.5%-18.5%
Range-$109.00M – -$14.00M
CAGR+67.0%
Avg YoY Growth-76.3%
Median YoY Growth-54.1%
Current Streak4+ years decline

Frequently Asked Questions

What is Morgan Stanley's derivative gain (loss) excluded from effectiveness?
Morgan Stanley (MS) reported derivative gain (loss) excluded from effectiveness of -$27.25M in Q4 2025.
How has Morgan Stanley's derivative gain (loss) excluded from effectiveness changed year-over-year?
Morgan Stanley's derivative gain (loss) excluded from effectiveness decreased by 18.5% year-over-year, from -$23.00M to -$27.25M.
What is the long-term trend for Morgan Stanley's derivative gain (loss) excluded from effectiveness?
Over 4 years (2021 to 2025), Morgan Stanley's derivative gain (loss) excluded from effectiveness has grown at a 67.0% compound annual growth rate (CAGR), from -$14.00M to -$109.00M.